International Journal of Clinical Practice · 2000 · 27 citations · 33 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyRenal PharmacotherapyBlood Pressure ControlBlood Pressure ManagementHypertension ControlHypertension ManagementHypertension PharmacotherapyHypertension PreventionAntihypertensive Drug TherapyAntihypertensive Medication ClassesAntihypertensive PharmacologyAntihypertensive TreatmentBlood PressureCombination Therapy
SUMMARY Treatment of hypertensive patients with fixed‐dose combination therapy consisting of losartan and hydrochlorothiazide (HCTZ) has several potential benefits over monotherapy with each of the individual components: more effective blood pressure control, a reduction in the likelihood of adverse effects, and facilitation of patients staying on therapy due to a simple once‐daily regimen. Losartan plus HCTZ fixed‐dose combination therapy lowers blood pressure in mild to moderate or severe hypertensive patients to a level comparable with other classes of antihypertensive drugs in combination with HCTZ. Fixed‐dose combination therapy with losartan plus HCTZ is therefore an excellent choice for hypertensive patients in whom combination therapy is necessary to achieve additional blood pressure reductions. (Int J Clin Pract 2000; 54(1): 48‐54)
33
Lennart Hansson, Alberto Zanchetti, S. George Carruthers et al. · The Lancet · 1998 · 5.8K citations
Prevalence of Hypertension in the US Adult Population
Vicki L. Burt, Paul K. Whelton, Edward J. Roccella et al. · Hypertension · 1995 · 3K citations
Public Health, Population Health Sciences, Behavioral Epidemiology +16